American Regent announces results from phase 3 HEART-FID trial with INJECTAFER®
August 28, 2023- American Regent, Inc. announced results from the phase 3 HEART-FID trial of INJECTAFER® (ferric carboxymaltose injection) for the treatment of iron deficiency…